CN Patent

CN101528214B — 取代的n-酰基苯胺及其使用方法

Assigned to University of Tennessee Research Foundation · Expires 2013-06-05 · 13y expired

What this patent protects

本发明提供了SARM化合物及其在治疗个体的多种疾病或病症方面的用途，所述疾病或病症特别包括肌萎缩疾病和/或障碍或骨相关疾病和/或障碍。

USPTO Abstract

本发明提供了SARM化合物及其在治疗个体的多种疾病或病症方面的用途，所述疾病或病症特别包括肌萎缩疾病和/或障碍或骨相关疾病和/或障碍。

Drugs covered by this patent

elacestrant-hydrochloride (ELACESTRANT HYDROCHLORIDE)

Patent Metadata

Patent number: CN101528214B
Jurisdiction: CN
Classification: —
Expires: 2013-06-05
Drug substance claim: No
Drug product claim: No
Assignee: University of Tennessee Research Foundation
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.